Amway announced its financial results for the full-year 2023, reporting total sales of $7.7 Billion, a 5% decline from 2022. The company attributes this decrease to the continued impact of ceasing Russian operations in 2022.
“Amway is committed to empowering millions of Amway Business Owners (ABOs) to help a billion people improve their healthspan–or the number of years they are healthy and feeling their best,” said Milind Pant, Amway Chief Executive Officer. “We do this by providing ABOs with innovative products, programs and solutions that allow them to pursue their own holistic wellbeing and help others in their communities do the same.”
Additionally, the company announced plans to invest more than $100 million in improving and expanding its manufacturing capabilities over the next three years, including state-of-the-art nutritional tableting at its Spaulding facility, and Pilot and Quality Control Labs at its world headquarters. The company will also renovate nearly 90,000 square feet of collaboration spaces at its campus to provide communal spaces, a new cafeteria and a new central campus entrance.
